Skip to main content

Table 5 Involvement of SNHG16 in cancer prognosis

From: LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers

Cancer type

Prognostic indicator

Associated clinical features

Ref.

Bladder cancer

OS

tumor stage, histological grade, lymph node metastasis

[23, 25]

Cervical cancer

OS

tumor size, tumor differentiation, lymph node metastasis, FIGO stage

[28, 29]

Colorectal Cancer

OS

–

[32]

Endometrial carcinoma

OS, recurrence free survival

–

[34]

Esophageal squamous cell carcinoma

OS

tumor stage, clinical stage, lymph nodes metastasis

[36]

Gastric Cancer

OS

tumor size, tumor differentiation, TNM stage, lymph node metastasis

[37, 38]

Glioma

OS, PFS

tumor size, WHO grade

[41]

Hepatocellular carcinoma

OS, PFS

tumor size, TNM stage

[45, 46, 49, 50]

Neuroblastoma

OS, event free survival

–

[20, 52]

Non small cell lung cancer

OS, DFS

tumor size, TNM stage, lymph node metastasis

[53]

Osteosarcoma

OS

–

[57, 59]

Ovarian cancer

OS

clinical stage, distance metastasis

[60]

Pancreatic cancer

OS

TNM stage, tumor differentiation, distant metastasis

[61]